MANY MINDEDMedical groups issue updated respiratory vaccine guidelines amid CDC restructuring
On September 2, 2026, professional medical organizations representing pediatricians, family physicians, obstetricians, and other medical professionals released updated vaccination guidelines for influenza, SARS-CoV-2, and respiratory syncytial virus (RSV). The guidelines followed the collapse of CDC collaboration under the Trump administration, after the Centers for Disease Control and Prevention (CDC) dismantled its Advisory Committee on Immunization Practices (ACIP) in June 2025 following Robert F. Kennedy Jr. firing its members. The CDC stated that influenza vaccination recommendations from July 2025 would remain in effect for the 2026-2027 season, while the guidelines were developed with the University of Minnesota's Vaccine Integrity Project and rationale published in the Journal of the American Medical Association.
The guidelines extend RSV vaccination access for pregnant people to March 1 of the following year, beginning September 1. The Vaccines for Children program continues to provide free vaccines for approximately half the nation's children for influenza, SARS-CoV-2, and RSV. For infants under 8 months entering their first RSV season, RSV monoclonal antibodies are recommended if mothers did not receive RSV vaccination during pregnancy or vaccination status is unclear.
This moves respiratory illness access by maintaining free vaccine coverage for children through the Vaccines for Children program and extending RSV vaccination windows for pregnant people. However, the CDC's flu recommendations apply only to the 2026-2027 season, and RSV antibody recommendations target specific infant populations as defined by the American Academy of Pediatrics.
What to watch: The ACIP remains in legal limbo due to a court challenge, and the RSV extension applies only to pregnant people. Antibody recommendations are limited to high-risk infants under 8 months with unclear vaccination status.
Source: STAT